HLN
Haleon plc · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers):
breedte van houders -5.9% ·
aandelenstroom -4.5% ·
netto nieuwe posities -12.5%
· formule
Brede distributie: dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 156.92K | $1.42M | n/a | n/a |
| Q2 2026 | 105 | +5 | 532.53M | $4.91B | +8 | −2 |
| Q1 2026 | 100 | +1 | 506.60M | $5.01B | +6 | −6 |
| Q4 2025 | 99 | -2 | 494.67M | $4.94B | +1 | −2 |
| Q3 2025 | 16 | -1 | 341.18M | $3.06B | +1 | −3 |
| Q2 2025 | 15 | 0 | 306.18M | $3.18B | +2 | −2 |
| Q1 2025 | 13 | 0 | 210.33M | $2.16B | n/a | n/a |
| Q4 2024 | 13 | +1 | 208.23M | $1.99B | +2 | −1 |
| Q3 2024 | 11 | 0 | 206.41M | $2.18B | +2 | −2 |
| Q2 2024 | 11 | n/a | 210.64M | $1.74B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 154.38M | -0.7% | $1.38B | 0.7% | ▼ Trim | 6 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 104.00M | -6.9% | $932.90M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 3 | JPMorgan Chase ✦ | 23.97M | n/a | $215.01M | 0.0% | n/c | 1 | SEC ↗ ×26 |
| 4 | Morgan Stanley ✦ | 18.53M | n/a | $166.24M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 5 | Wellington Management ✦ | 15.68M | -6.0% | $140.65M | 0.0% | ▼ Trim | 6 | SEC ↗ ×6 |
| 6 | Goldman Sachs Group ✦ | 8.85M | n/a | $79.40M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 7 | BlackRock ✦ (passief) | 6.25M | -2.7% | $56.06M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 8 | Citadel Advisors ✦ | 3.72M | -18.6% | $33.37M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | Point72 Asset Management ✦ | 2.36M | +2542.4% | $21.19M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 1.43M | -81.6% | $12.87M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | Millennium Management ✦ | 971.81K | -54.8% | $8.72M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 331.62K | -6.3% | $2.97M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | State Street Global Advisors ✦ (passief) | 292.85K | -6.4% | $2.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 181.80K | Nieuw | $1.63M | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 138.75K | +8.3% | $1.24M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 16 | Tweedy, Browne ✦ | 76.67K | -0.2% | $687,712 | 0.1% | ▼ Trim | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Arrowstreet Capital | $1.63M | 0.0% |
Verlaten
| Norges Bank | $2.85M | was 0.0% |
| Marshall Wace | $631,989 | was 0.0% |
| Two Sigma Investments | $371,630 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 618 houders, 559.47M aandelen, $5.40B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.